Xanthoangelol and 4-Hydroxyderricin Are the Major Active Principles of the Inhibitory Activities against Monoamine Oxidases on Angelica keiskei K
Open Access
- 31 May 2013
- journal article
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 21 (3), 234-240
- https://doi.org/10.4062/biomolther.2012.100
Abstract
Monoamine oxidase inhibitors (MAOI) have been widely used as antidepressants. Recently, there has been renewed interest in MAO inhibitors. The activity-guided fractionation of extracts from Angelica keiskei Koidzumi (A. keiskei K.) led to the isolation of two prenylated chalcones, xanthoangelol and 4-hydroxyderricin and a flavonoid, cynaroside. These three isolated compounds are the major active ingredients of A. keiskei K. to inhibit the MAOs and DBH activities. Xanthoangelol is a nonselective MAO inhibitor, and a potent dopamine β-hydroxylase (DBH) inhibitor. IC50 values of xanthoangelol to MAO-A and MAO-B were calculated to be 43.4 μM, and 43.9 μM. These values were very similar to iproniazid, which is a nonselective MAO inhibitor used as a drug against depression. The IC50 values of iproniazid were 37 μM, and 42.5 μM in our parallel examination. Moreover, IC50 value of xanthoangelol to DBH was calculated 0.52 μM. 4-Hydroxyderricin is a potent selective MAO-B inhibitor and also mildly inhibits DBH activity. The IC50 value of 4-hydroxyderricin to MAO-B was calculated to be 3.43 μM and this value was higher than that of deprenyl (0.046 μM) used as a positive control for selective MAO-B inhibitor in our test. Cynaroside is a most potent DBH inhibitor. The IC50 value of cynaroside to DBH was calculated at 0.0410 μM. Results of this study suggest that the two prenylated chalcones, xanthoangelol and 4-hydroxyderricin isolated from A. keiskei K., are expected for potent candidates for development of combined antidepressant drug. A. keiskei K. will be an excellent new bio-functional food material that has the combined antidepressant effect.Keywords
This publication has 22 references indexed in Scilit:
- Monoamine Oxidase and Dopamine β-Hydroxylase Inhibitors from the Fruits of Gardenia jasminoidesBiomolecules & Therapeutics, 2012
- MAO inhibitors: Risks, benefits, and loreCleveland Clinic Journal of Medicine, 2010
- Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in β-phenylethylamineEuropean Journal of Pharmacology, 2010
- Hypotensive and lipid regulatory actions of 4‐hydroxyderricin, a chalcone from Angelica keiskei, in stroke‐prone spontaneously hypertensive ratsClinical and Experimental Pharmacology and Physiology, 2005
- Meta-Analysis of the Reversible Inhibitors of Monoamine Oxidase Type A Moclobemide and Brofaromine for the Treatment of DepressionNeuropsychopharmacology, 1999
- Effects of Angiotensin I-Converting Enzyme Inhibitor from Ashitaba (Angelica keiskei) on Blood Pressure of Spontaneously Hypertensive Rats.Journal of Nutritional Science and Vitaminology, 1999
- Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depressionActa Psychiatrica Scandinavica, 1991
- Anti-Tumor-Promotion by Principles Obtained fromAngelica keiskeiPlanta Medica, 1991
- Chalcones from Angelica keiskeiPhytochemistry, 1990
- Clinical and pharmacological problems of deprenyl (selegiline) treatment in Parkinson's diseaseActa Neurologica Scandinavica, 1983